250 related articles for article (PubMed ID: 2966965)
1. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
Gray RE; Yates AJ; Preston CJ; Smith R; Russell RG; Kanis JA
Q J Med; 1987 Sep; 64(245):755-67. PubMed ID: 2966965
[TBL] [Abstract][Full Text] [Related]
2. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
Chapuy MC; Charhon SA; Meunier PJ
Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
[TBL] [Abstract][Full Text] [Related]
4. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
Davoine GA; Jung A; Courvoisier B
Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
[TBL] [Abstract][Full Text] [Related]
6. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
Krane SM
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):186-7. PubMed ID: 16932682
[No Abstract] [Full Text] [Related]
7. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
Yates AJ; Percival RC; Gray RE; Atkins RM; Urwin GH; Hamdy NA; Preston CJ; Beneton MN; Russell RG; Kanis JA
Lancet; 1985 Jun; 1(8444):1474-7. PubMed ID: 2861411
[TBL] [Abstract][Full Text] [Related]
8. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
Sieghart S
Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
[TBL] [Abstract][Full Text] [Related]
9. Improvement in the deformity of the face in Paget's disease treated with diphosphonates.
Bickerstaff DR; Douglas DL; Burke PH; O'Doherty DP; Kanis JA
J Bone Joint Surg Br; 1990 Jan; 72(1):132-6. PubMed ID: 2137127
[TBL] [Abstract][Full Text] [Related]
10. Aminohexane diphosphonate in the treatment of Paget's disease of bone.
Atkins RM; Yates AJ; Gray RE; Urwin GH; Hamdy NA; Beneton MN; Rosini S; Kanis JA
J Bone Miner Res; 1987 Aug; 2(4):273-9. PubMed ID: 3455614
[TBL] [Abstract][Full Text] [Related]
11. Short courses of intravenous clodronate in the treatment of Paget's disease of bone: a long-term follow-up trial.
Broggini M; Baratelli E; Cappelli A; Marconi A; Ghiringhelli D; Salzillo A
Int J Clin Pharmacol Res; 1993; 13(6):301-4. PubMed ID: 8088930
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
Bone; 1985; 6(2):69-72. PubMed ID: 2409999
[TBL] [Abstract][Full Text] [Related]
13. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
[TBL] [Abstract][Full Text] [Related]
14. [Etidronic acid therapy in Paget's disease of bone].
Holz G; Delling G; Ziegler R
Dtsch Med Wochenschr; 1983 Dec; 108(51-52):1954-8. PubMed ID: 6418505
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.
McCloskey EV; Yates AJ; Beneton MN; Galloway J; Harris S; Kanis JA
Bone; 1987; 8 Suppl 1():S35-41. PubMed ID: 2825741
[TBL] [Abstract][Full Text] [Related]
16. Diphosphonates in Paget's disease.
Russell RG; Smith R; Preston C; Walton RJ; Woods CG
Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
[No Abstract] [Full Text] [Related]
17. [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
Reginster JY; Gritten C; Diverse P; Hauwaert PC; Crielaard JM; Halleux R; Franchimont P
Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):145-50. PubMed ID: 3923603
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of Paget's disease paraplegia with diphosphonates : preliminary results (author's transl)].
Alexandre C; Trillet M; Meunier P; Fischer C
Rev Neurol (Paris); 1979 Oct; 135(8-9):625-32. PubMed ID: 161056
[TBL] [Abstract][Full Text] [Related]
19. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
